BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Tamoxifen
,
rs2300478
,
VEGFA
,
calcium channel activity
,
Allergy to pollen
,
Heart
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
MAP kinase p38
Summary
General Info
Curated Studies
Most Correlated Studies
HUVEC cells HPAIV H7N7 infected and/or p38-inhibitor SB 202190 treated
GRA24 modulation of immune response to infection by sustained host p38 MAPK activation
Ras, MKK3, and MKK7 targeted MAP Kinase activation in mouse heart
Fibroblasts serum starved treated with anisomycin for 3 or 6hr with or without H89 pre-treatment
Glioblastoma LN229 cells treated with UM-164
Explore Curated Studies Results
Literature
Most Relevant Literature
Atorvastatin protects against cyclophosphamide-induced thyroid injury in rats via modulation of JNK/…
Dexmedetomidine Alleviates Lipopolysaccharide-Induced Hippocampal Neuronal Apoptosis via Inhibiting …
Anti-Inflammatory Profile of Jungia sellowii Less. by Downregulation of Proinflammatory Mediators an…
Chlorogenic Acid Alleviates Chronic Stress-Induced Intestinal Damage by Inhibiting the P38MAPK/NF-κB…
Role of p38 inhibition in cardiac ischemia/reperfusion injury.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Clinical Pharmacology of p38 MAP Kinase Inhibitor, VX-745, in Mild Cognitive Impairment Due to Alzhe…
A PET Study of the Effects of p38 MAP Kinase Inhibitor, VX-745, on Amyloid Plaque Load in Alzheimer'…
A Study in Rheumatoid Arthritis With an Investigational Oral p38 MAP Kinase Inhibitor VX-702
Phase 2 Clinical Study in Rheumatoid Arthritis With an Investigational Oral p38 MAP Kinase Inhibitor…
P38 Mitogen-activated Protein (Map) Kinase Inhibitor (SB-681323)Study In Patients With Neuropathic P…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ